nodes	percent_of_prediction	percent_of_DWPC	metapath
Triazolam—Menstruation irregular—Spironolactone—dilated cardiomyopathy	0.0481	0.0604	CcSEcCtD
Triazolam—Incontinence—Furosemide—dilated cardiomyopathy	0.0415	0.0521	CcSEcCtD
Triazolam—Dysaesthesia—Lisinopril—dilated cardiomyopathy	0.0251	0.0316	CcSEcCtD
Triazolam—Sleep disturbance—Lisinopril—dilated cardiomyopathy	0.0194	0.0244	CcSEcCtD
Triazolam—Ataxia—Spironolactone—dilated cardiomyopathy	0.0182	0.0228	CcSEcCtD
Triazolam—Cramp muscle—Spironolactone—dilated cardiomyopathy	0.0174	0.0219	CcSEcCtD
Triazolam—Hearing impaired—Furosemide—dilated cardiomyopathy	0.0152	0.0191	CcSEcCtD
Triazolam—Drowsiness—Spironolactone—dilated cardiomyopathy	0.0149	0.0187	CcSEcCtD
Triazolam—Memory impairment—Lisinopril—dilated cardiomyopathy	0.0139	0.0174	CcSEcCtD
Triazolam—Lightheadedness—Furosemide—dilated cardiomyopathy	0.013	0.0163	CcSEcCtD
Triazolam—Mental disability—Furosemide—dilated cardiomyopathy	0.0126	0.0158	CcSEcCtD
Triazolam—Deafness—Furosemide—dilated cardiomyopathy	0.0118	0.0148	CcSEcCtD
Triazolam—Muscle spasms—Spironolactone—dilated cardiomyopathy	0.0112	0.0141	CcSEcCtD
Triazolam—Ill-defined disorder—Spironolactone—dilated cardiomyopathy	0.0108	0.0136	CcSEcCtD
Triazolam—Malaise—Spironolactone—dilated cardiomyopathy	0.0105	0.0132	CcSEcCtD
Triazolam—Irritability—Furosemide—dilated cardiomyopathy	0.01	0.0126	CcSEcCtD
Triazolam—Urinary retention—Furosemide—dilated cardiomyopathy	0.01	0.0126	CcSEcCtD
Triazolam—Discomfort—Spironolactone—dilated cardiomyopathy	0.00979	0.0123	CcSEcCtD
Triazolam—Lightheadedness—Lisinopril—dilated cardiomyopathy	0.00973	0.0122	CcSEcCtD
Triazolam—Confusional state—Spironolactone—dilated cardiomyopathy	0.00958	0.012	CcSEcCtD
Triazolam—Cramp muscle—Furosemide—dilated cardiomyopathy	0.00947	0.0119	CcSEcCtD
Triazolam—Muscular weakness—Furosemide—dilated cardiomyopathy	0.00928	0.0117	CcSEcCtD
Triazolam—Sleep disorder—Lisinopril—dilated cardiomyopathy	0.00912	0.0114	CcSEcCtD
Triazolam—Hepatic failure—Lisinopril—dilated cardiomyopathy	0.00878	0.011	CcSEcCtD
Triazolam—Somnolence—Spironolactone—dilated cardiomyopathy	0.00845	0.0106	CcSEcCtD
Triazolam—Drowsiness—Furosemide—dilated cardiomyopathy	0.00811	0.0102	CcSEcCtD
Triazolam—Osteoarthritis—Lisinopril—dilated cardiomyopathy	0.00789	0.00991	CcSEcCtD
Triazolam—Feeling abnormal—Spironolactone—dilated cardiomyopathy	0.00783	0.00983	CcSEcCtD
Triazolam—Irritability—Lisinopril—dilated cardiomyopathy	0.00753	0.00946	CcSEcCtD
Triazolam—Ataxia—Lisinopril—dilated cardiomyopathy	0.00742	0.00932	CcSEcCtD
Triazolam—Cramp muscle—Lisinopril—dilated cardiomyopathy	0.00711	0.00892	CcSEcCtD
Triazolam—Visual impairment—Furosemide—dilated cardiomyopathy	0.00701	0.00881	CcSEcCtD
Triazolam—Hypersensitivity—Spironolactone—dilated cardiomyopathy	0.007	0.00879	CcSEcCtD
Triazolam—Tinnitus—Furosemide—dilated cardiomyopathy	0.00678	0.00852	CcSEcCtD
Triazolam—Pruritus—Spironolactone—dilated cardiomyopathy	0.00672	0.00844	CcSEcCtD
Triazolam—Sweating increased—Lisinopril—dilated cardiomyopathy	0.00664	0.00834	CcSEcCtD
Triazolam—Diarrhoea—Spironolactone—dilated cardiomyopathy	0.0065	0.00816	CcSEcCtD
Triazolam—Dysuria—Lisinopril—dilated cardiomyopathy	0.00638	0.00801	CcSEcCtD
Triazolam—Erythema—Furosemide—dilated cardiomyopathy	0.00633	0.00795	CcSEcCtD
Triazolam—Dizziness—Spironolactone—dilated cardiomyopathy	0.00628	0.00789	CcSEcCtD
Triazolam—Flatulence—Furosemide—dilated cardiomyopathy	0.00624	0.00784	CcSEcCtD
Triazolam—Dysgeusia—Furosemide—dilated cardiomyopathy	0.0062	0.00779	CcSEcCtD
Triazolam—Muscle spasms—Furosemide—dilated cardiomyopathy	0.00609	0.00765	CcSEcCtD
Triazolam—Vomiting—Spironolactone—dilated cardiomyopathy	0.00604	0.00759	CcSEcCtD
Triazolam—Dermatitis—Spironolactone—dilated cardiomyopathy	0.00599	0.00752	CcSEcCtD
Triazolam—Headache—Spironolactone—dilated cardiomyopathy	0.00595	0.00748	CcSEcCtD
Triazolam—Jaundice—Lisinopril—dilated cardiomyopathy	0.00593	0.00744	CcSEcCtD
Triazolam—Agitation—Furosemide—dilated cardiomyopathy	0.00582	0.00731	CcSEcCtD
Triazolam—Nausea—Spironolactone—dilated cardiomyopathy	0.00564	0.00709	CcSEcCtD
Triazolam—Hallucination—Lisinopril—dilated cardiomyopathy	0.00543	0.00682	CcSEcCtD
Triazolam—Dry mouth—Furosemide—dilated cardiomyopathy	0.00527	0.00662	CcSEcCtD
Triazolam—Confusional state—Furosemide—dilated cardiomyopathy	0.00521	0.00655	CcSEcCtD
Triazolam—Tinnitus—Lisinopril—dilated cardiomyopathy	0.00509	0.00639	CcSEcCtD
Triazolam—Shock—Furosemide—dilated cardiomyopathy	0.00509	0.00639	CcSEcCtD
Triazolam—Hyperhidrosis—Furosemide—dilated cardiomyopathy	0.005	0.00628	CcSEcCtD
Triazolam—CYP2C9—cardial valve—dilated cardiomyopathy	0.00494	0.452	CbGeAlD
Triazolam—Anorexia—Furosemide—dilated cardiomyopathy	0.00493	0.00619	CcSEcCtD
Triazolam—Erythema—Lisinopril—dilated cardiomyopathy	0.00475	0.00597	CcSEcCtD
Triazolam—Flatulence—Lisinopril—dilated cardiomyopathy	0.00468	0.00588	CcSEcCtD
Triazolam—Tension—Lisinopril—dilated cardiomyopathy	0.00466	0.00586	CcSEcCtD
Triazolam—Dysgeusia—Lisinopril—dilated cardiomyopathy	0.00465	0.00584	CcSEcCtD
Triazolam—Paraesthesia—Furosemide—dilated cardiomyopathy	0.00464	0.00583	CcSEcCtD
Triazolam—Nervousness—Lisinopril—dilated cardiomyopathy	0.00462	0.0058	CcSEcCtD
Triazolam—Somnolence—Furosemide—dilated cardiomyopathy	0.0046	0.00577	CcSEcCtD
Triazolam—Muscle spasms—Lisinopril—dilated cardiomyopathy	0.00457	0.00574	CcSEcCtD
Triazolam—Decreased appetite—Furosemide—dilated cardiomyopathy	0.00449	0.00564	CcSEcCtD
Triazolam—Fatigue—Furosemide—dilated cardiomyopathy	0.00446	0.0056	CcSEcCtD
Triazolam—Tremor—Lisinopril—dilated cardiomyopathy	0.00445	0.00559	CcSEcCtD
Triazolam—Pain—Furosemide—dilated cardiomyopathy	0.00442	0.00555	CcSEcCtD
Triazolam—Constipation—Furosemide—dilated cardiomyopathy	0.00442	0.00555	CcSEcCtD
Triazolam—Ill-defined disorder—Lisinopril—dilated cardiomyopathy	0.00441	0.00554	CcSEcCtD
Triazolam—Malaise—Lisinopril—dilated cardiomyopathy	0.00429	0.00538	CcSEcCtD
Triazolam—Syncope—Lisinopril—dilated cardiomyopathy	0.00426	0.00535	CcSEcCtD
Triazolam—Feeling abnormal—Furosemide—dilated cardiomyopathy	0.00426	0.00535	CcSEcCtD
Triazolam—Gastrointestinal pain—Furosemide—dilated cardiomyopathy	0.00423	0.00531	CcSEcCtD
Triazolam—Palpitations—Lisinopril—dilated cardiomyopathy	0.0042	0.00527	CcSEcCtD
Triazolam—Loss of consciousness—Lisinopril—dilated cardiomyopathy	0.00418	0.00525	CcSEcCtD
Triazolam—Abdominal pain—Furosemide—dilated cardiomyopathy	0.00409	0.00513	CcSEcCtD
Triazolam—Chest pain—Lisinopril—dilated cardiomyopathy	0.00405	0.00508	CcSEcCtD
Triazolam—Anxiety—Lisinopril—dilated cardiomyopathy	0.00403	0.00506	CcSEcCtD
Triazolam—Discomfort—Lisinopril—dilated cardiomyopathy	0.004	0.00502	CcSEcCtD
Triazolam—Dry mouth—Lisinopril—dilated cardiomyopathy	0.00396	0.00497	CcSEcCtD
Triazolam—Confusional state—Lisinopril—dilated cardiomyopathy	0.00391	0.00491	CcSEcCtD
Triazolam—Oedema—Lisinopril—dilated cardiomyopathy	0.00388	0.00487	CcSEcCtD
Triazolam—Shock—Lisinopril—dilated cardiomyopathy	0.00382	0.00479	CcSEcCtD
Triazolam—Hypersensitivity—Furosemide—dilated cardiomyopathy	0.00381	0.00478	CcSEcCtD
Triazolam—Tachycardia—Lisinopril—dilated cardiomyopathy	0.00379	0.00475	CcSEcCtD
Triazolam—Hyperhidrosis—Lisinopril—dilated cardiomyopathy	0.00375	0.00471	CcSEcCtD
Triazolam—Asthenia—Furosemide—dilated cardiomyopathy	0.00371	0.00466	CcSEcCtD
Triazolam—Anorexia—Lisinopril—dilated cardiomyopathy	0.0037	0.00464	CcSEcCtD
Triazolam—Pruritus—Furosemide—dilated cardiomyopathy	0.00366	0.00459	CcSEcCtD
Triazolam—Diarrhoea—Furosemide—dilated cardiomyopathy	0.00354	0.00444	CcSEcCtD
Triazolam—Insomnia—Lisinopril—dilated cardiomyopathy	0.00351	0.00441	CcSEcCtD
Triazolam—Paraesthesia—Lisinopril—dilated cardiomyopathy	0.00348	0.00437	CcSEcCtD
Triazolam—Dyspnoea—Lisinopril—dilated cardiomyopathy	0.00346	0.00434	CcSEcCtD
Triazolam—Somnolence—Lisinopril—dilated cardiomyopathy	0.00345	0.00433	CcSEcCtD
Triazolam—Dizziness—Furosemide—dilated cardiomyopathy	0.00342	0.00429	CcSEcCtD
Triazolam—Decreased appetite—Lisinopril—dilated cardiomyopathy	0.00337	0.00423	CcSEcCtD
Triazolam—Fatigue—Lisinopril—dilated cardiomyopathy	0.00334	0.0042	CcSEcCtD
Triazolam—Constipation—Lisinopril—dilated cardiomyopathy	0.00332	0.00417	CcSEcCtD
Triazolam—Pain—Lisinopril—dilated cardiomyopathy	0.00332	0.00417	CcSEcCtD
Triazolam—Vomiting—Furosemide—dilated cardiomyopathy	0.00329	0.00413	CcSEcCtD
Triazolam—Dermatitis—Furosemide—dilated cardiomyopathy	0.00326	0.00409	CcSEcCtD
Triazolam—Headache—Furosemide—dilated cardiomyopathy	0.00324	0.00407	CcSEcCtD
Triazolam—Feeling abnormal—Lisinopril—dilated cardiomyopathy	0.0032	0.00401	CcSEcCtD
Triazolam—Gastrointestinal pain—Lisinopril—dilated cardiomyopathy	0.00317	0.00398	CcSEcCtD
Triazolam—Nausea—Furosemide—dilated cardiomyopathy	0.00307	0.00386	CcSEcCtD
Triazolam—Abdominal pain—Lisinopril—dilated cardiomyopathy	0.00307	0.00385	CcSEcCtD
Triazolam—Hypersensitivity—Lisinopril—dilated cardiomyopathy	0.00286	0.00359	CcSEcCtD
Triazolam—Asthenia—Lisinopril—dilated cardiomyopathy	0.00278	0.0035	CcSEcCtD
Triazolam—Pruritus—Lisinopril—dilated cardiomyopathy	0.00274	0.00345	CcSEcCtD
Triazolam—Diarrhoea—Lisinopril—dilated cardiomyopathy	0.00265	0.00333	CcSEcCtD
Triazolam—Dizziness—Lisinopril—dilated cardiomyopathy	0.00256	0.00322	CcSEcCtD
Triazolam—Vomiting—Lisinopril—dilated cardiomyopathy	0.00247	0.0031	CcSEcCtD
Triazolam—Dermatitis—Lisinopril—dilated cardiomyopathy	0.00244	0.00307	CcSEcCtD
Triazolam—Headache—Lisinopril—dilated cardiomyopathy	0.00243	0.00305	CcSEcCtD
Triazolam—Nausea—Lisinopril—dilated cardiomyopathy	0.0023	0.00289	CcSEcCtD
Triazolam—GABRB1—Ion channel transport—RYR2—dilated cardiomyopathy	0.00197	0.0102	CbGpPWpGaD
Triazolam—GABRG3—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—ACTN2—dilated cardiomyopathy	0.00195	0.0101	CbGpPWpGaD
Triazolam—GABRA1—SIDS Susceptibility Pathways—SCN5A—dilated cardiomyopathy	0.00194	0.0101	CbGpPWpGaD
Triazolam—GABRG3—Ion channel transport—PLN—dilated cardiomyopathy	0.00194	0.0101	CbGpPWpGaD
Triazolam—GABRB1—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—ACTN2—dilated cardiomyopathy	0.00192	0.00995	CbGpPWpGaD
Triazolam—GABRB1—Ion channel transport—PLN—dilated cardiomyopathy	0.00191	0.00993	CbGpPWpGaD
Triazolam—GABRR1—Transmission across Chemical Synapses—ACTN2—dilated cardiomyopathy	0.00186	0.00966	CbGpPWpGaD
Triazolam—GABRA6—Ion channel transport—RYR2—dilated cardiomyopathy	0.00186	0.00966	CbGpPWpGaD
Triazolam—GABRA4—Ion channel transport—RYR2—dilated cardiomyopathy	0.00184	0.00954	CbGpPWpGaD
Triazolam—GABRA6—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—ACTN2—dilated cardiomyopathy	0.00181	0.00941	CbGpPWpGaD
Triazolam—GABRA6—Ion channel transport—PLN—dilated cardiomyopathy	0.00181	0.0094	CbGpPWpGaD
Triazolam—GABRA4—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—ACTN2—dilated cardiomyopathy	0.00179	0.00929	CbGpPWpGaD
Triazolam—GABRA4—Ion channel transport—PLN—dilated cardiomyopathy	0.00179	0.00928	CbGpPWpGaD
Triazolam—GABRQ—Transmission across Chemical Synapses—ACTN2—dilated cardiomyopathy	0.00178	0.00922	CbGpPWpGaD
Triazolam—GABRR2—Transmission across Chemical Synapses—ACTN2—dilated cardiomyopathy	0.00178	0.00922	CbGpPWpGaD
Triazolam—GABRB2—Ion channel transport—RYR2—dilated cardiomyopathy	0.00168	0.00872	CbGpPWpGaD
Triazolam—GABRB2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—ACTN2—dilated cardiomyopathy	0.00164	0.0085	CbGpPWpGaD
Triazolam—GABRB2—Ion channel transport—PLN—dilated cardiomyopathy	0.00164	0.00848	CbGpPWpGaD
Triazolam—GABRA5—Ion channel transport—RYR2—dilated cardiomyopathy	0.00163	0.00847	CbGpPWpGaD
Triazolam—GABRA3—Ion channel transport—RYR2—dilated cardiomyopathy	0.0016	0.00832	CbGpPWpGaD
Triazolam—GABRA5—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—ACTN2—dilated cardiomyopathy	0.00159	0.00826	CbGpPWpGaD
Triazolam—GABRA5—Ion channel transport—PLN—dilated cardiomyopathy	0.00159	0.00824	CbGpPWpGaD
Triazolam—GABRA2—Ion channel transport—RYR2—dilated cardiomyopathy	0.00158	0.00818	CbGpPWpGaD
Triazolam—GABRB3—Ion channel transport—RYR2—dilated cardiomyopathy	0.00157	0.00812	CbGpPWpGaD
Triazolam—GABRA3—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—ACTN2—dilated cardiomyopathy	0.00156	0.00811	CbGpPWpGaD
Triazolam—GABRA3—Ion channel transport—PLN—dilated cardiomyopathy	0.00156	0.00809	CbGpPWpGaD
Triazolam—GABRG2—Ion channel transport—RYR2—dilated cardiomyopathy	0.00154	0.00798	CbGpPWpGaD
Triazolam—GABRA2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—ACTN2—dilated cardiomyopathy	0.00154	0.00797	CbGpPWpGaD
Triazolam—GABRA2—Ion channel transport—PLN—dilated cardiomyopathy	0.00153	0.00795	CbGpPWpGaD
Triazolam—GABRB3—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—ACTN2—dilated cardiomyopathy	0.00153	0.00792	CbGpPWpGaD
Triazolam—GABRB3—Ion channel transport—PLN—dilated cardiomyopathy	0.00152	0.0079	CbGpPWpGaD
Triazolam—GABRG2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—ACTN2—dilated cardiomyopathy	0.0015	0.00777	CbGpPWpGaD
Triazolam—GABRG2—Ion channel transport—PLN—dilated cardiomyopathy	0.0015	0.00776	CbGpPWpGaD
Triazolam—GABRR1—Neuronal System—ABCC9—dilated cardiomyopathy	0.00149	0.00772	CbGpPWpGaD
Triazolam—GABRG3—Transmission across Chemical Synapses—ACTN2—dilated cardiomyopathy	0.00146	0.00759	CbGpPWpGaD
Triazolam—GABRB1—Transmission across Chemical Synapses—ACTN2—dilated cardiomyopathy	0.00144	0.00748	CbGpPWpGaD
Triazolam—GABRR1—Neuronal System—ACTN2—dilated cardiomyopathy	0.00143	0.0074	CbGpPWpGaD
Triazolam—GABRR2—Neuronal System—ABCC9—dilated cardiomyopathy	0.00142	0.00737	CbGpPWpGaD
Triazolam—GABRQ—Neuronal System—ABCC9—dilated cardiomyopathy	0.00142	0.00737	CbGpPWpGaD
Triazolam—GABRA1—SIDS Susceptibility Pathways—RYR2—dilated cardiomyopathy	0.00139	0.00719	CbGpPWpGaD
Triazolam—GABRA6—Transmission across Chemical Synapses—ACTN2—dilated cardiomyopathy	0.00136	0.00707	CbGpPWpGaD
Triazolam—GABRR2—Neuronal System—ACTN2—dilated cardiomyopathy	0.00136	0.00706	CbGpPWpGaD
Triazolam—GABRQ—Neuronal System—ACTN2—dilated cardiomyopathy	0.00136	0.00706	CbGpPWpGaD
Triazolam—GABRA4—Transmission across Chemical Synapses—ACTN2—dilated cardiomyopathy	0.00135	0.00699	CbGpPWpGaD
Triazolam—GABRA1—Ion channel transport—RYR2—dilated cardiomyopathy	0.00134	0.00697	CbGpPWpGaD
Triazolam—GABRA1—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—ACTN2—dilated cardiomyopathy	0.00131	0.00679	CbGpPWpGaD
Triazolam—GABRA1—Ion channel transport—PLN—dilated cardiomyopathy	0.00131	0.00678	CbGpPWpGaD
Triazolam—GABRB2—Transmission across Chemical Synapses—ACTN2—dilated cardiomyopathy	0.00123	0.00639	CbGpPWpGaD
Triazolam—GABRA5—Transmission across Chemical Synapses—ACTN2—dilated cardiomyopathy	0.0012	0.00621	CbGpPWpGaD
Triazolam—GABRA3—Transmission across Chemical Synapses—ACTN2—dilated cardiomyopathy	0.00118	0.0061	CbGpPWpGaD
Triazolam—GABRG3—Neuronal System—ABCC9—dilated cardiomyopathy	0.00117	0.00607	CbGpPWpGaD
Triazolam—GABRA2—Transmission across Chemical Synapses—ACTN2—dilated cardiomyopathy	0.00116	0.00599	CbGpPWpGaD
Triazolam—GABRB1—Neuronal System—ABCC9—dilated cardiomyopathy	0.00115	0.00598	CbGpPWpGaD
Triazolam—GABRB3—Transmission across Chemical Synapses—ACTN2—dilated cardiomyopathy	0.00115	0.00595	CbGpPWpGaD
Triazolam—GABRG2—Transmission across Chemical Synapses—ACTN2—dilated cardiomyopathy	0.00113	0.00584	CbGpPWpGaD
Triazolam—GABRG3—Neuronal System—ACTN2—dilated cardiomyopathy	0.00112	0.00582	CbGpPWpGaD
Triazolam—GABRB1—Neuronal System—ACTN2—dilated cardiomyopathy	0.0011	0.00573	CbGpPWpGaD
Triazolam—GABRA6—Neuronal System—ABCC9—dilated cardiomyopathy	0.00109	0.00565	CbGpPWpGaD
Triazolam—GABRA4—Neuronal System—ABCC9—dilated cardiomyopathy	0.00108	0.00558	CbGpPWpGaD
Triazolam—GABRA6—Neuronal System—ACTN2—dilated cardiomyopathy	0.00105	0.00542	CbGpPWpGaD
Triazolam—GABRA4—Neuronal System—ACTN2—dilated cardiomyopathy	0.00103	0.00535	CbGpPWpGaD
Triazolam—GABRA1—Transmission across Chemical Synapses—ACTN2—dilated cardiomyopathy	0.000985	0.00511	CbGpPWpGaD
Triazolam—GABRB2—Neuronal System—ABCC9—dilated cardiomyopathy	0.000985	0.00511	CbGpPWpGaD
Triazolam—GABRA5—Neuronal System—ABCC9—dilated cardiomyopathy	0.000957	0.00496	CbGpPWpGaD
Triazolam—GABRB2—Neuronal System—ACTN2—dilated cardiomyopathy	0.000944	0.0049	CbGpPWpGaD
Triazolam—GABRA3—Neuronal System—ABCC9—dilated cardiomyopathy	0.000939	0.00487	CbGpPWpGaD
Triazolam—GABRA2—Neuronal System—ABCC9—dilated cardiomyopathy	0.000923	0.00479	CbGpPWpGaD
Triazolam—GABRA5—Neuronal System—ACTN2—dilated cardiomyopathy	0.000917	0.00476	CbGpPWpGaD
Triazolam—GABRB3—Neuronal System—ABCC9—dilated cardiomyopathy	0.000917	0.00476	CbGpPWpGaD
Triazolam—GABRA4—myocardium—dilated cardiomyopathy	0.000907	0.0829	CbGeAlD
Triazolam—GABRG2—Neuronal System—ABCC9—dilated cardiomyopathy	0.000901	0.00467	CbGpPWpGaD
Triazolam—GABRA3—Neuronal System—ACTN2—dilated cardiomyopathy	0.000901	0.00467	CbGpPWpGaD
Triazolam—GABRR1—Transmembrane transport of small molecules—RYR2—dilated cardiomyopathy	0.000885	0.00459	CbGpPWpGaD
Triazolam—GABRA2—Neuronal System—ACTN2—dilated cardiomyopathy	0.000885	0.00459	CbGpPWpGaD
Triazolam—GABRB3—Neuronal System—ACTN2—dilated cardiomyopathy	0.000879	0.00456	CbGpPWpGaD
Triazolam—GABRG2—Neuronal System—ACTN2—dilated cardiomyopathy	0.000863	0.00448	CbGpPWpGaD
Triazolam—GABRR1—Transmembrane transport of small molecules—SLC22A5—dilated cardiomyopathy	0.000861	0.00447	CbGpPWpGaD
Triazolam—GABRR1—Transmembrane transport of small molecules—PLN—dilated cardiomyopathy	0.000861	0.00447	CbGpPWpGaD
Triazolam—GABRR2—Transmembrane transport of small molecules—RYR2—dilated cardiomyopathy	0.000845	0.00438	CbGpPWpGaD
Triazolam—GABRQ—Transmembrane transport of small molecules—RYR2—dilated cardiomyopathy	0.000845	0.00438	CbGpPWpGaD
Triazolam—GABRR2—Transmembrane transport of small molecules—SLC22A5—dilated cardiomyopathy	0.000822	0.00426	CbGpPWpGaD
Triazolam—GABRR2—Transmembrane transport of small molecules—PLN—dilated cardiomyopathy	0.000822	0.00426	CbGpPWpGaD
Triazolam—GABRQ—Transmembrane transport of small molecules—SLC22A5—dilated cardiomyopathy	0.000822	0.00426	CbGpPWpGaD
Triazolam—GABRQ—Transmembrane transport of small molecules—PLN—dilated cardiomyopathy	0.000822	0.00426	CbGpPWpGaD
Triazolam—GABRR1—Transmembrane transport of small molecules—ABCC9—dilated cardiomyopathy	0.000801	0.00415	CbGpPWpGaD
Triazolam—GABRA1—Neuronal System—ABCC9—dilated cardiomyopathy	0.000787	0.00408	CbGpPWpGaD
Triazolam—GABRQ—Transmembrane transport of small molecules—ABCC9—dilated cardiomyopathy	0.000764	0.00396	CbGpPWpGaD
Triazolam—GABRR2—Transmembrane transport of small molecules—ABCC9—dilated cardiomyopathy	0.000764	0.00396	CbGpPWpGaD
Triazolam—GABRA1—Neuronal System—ACTN2—dilated cardiomyopathy	0.000755	0.00391	CbGpPWpGaD
Triazolam—GABRE—cardiac ventricle—dilated cardiomyopathy	0.000731	0.0668	CbGeAlD
Triazolam—GABRG3—Transmembrane transport of small molecules—RYR2—dilated cardiomyopathy	0.000695	0.00361	CbGpPWpGaD
Triazolam—GABRB1—Transmembrane transport of small molecules—RYR2—dilated cardiomyopathy	0.000685	0.00355	CbGpPWpGaD
Triazolam—TSPO—cardiac ventricle—dilated cardiomyopathy	0.000682	0.0624	CbGeAlD
Triazolam—GABRG3—Transmembrane transport of small molecules—SLC22A5—dilated cardiomyopathy	0.000677	0.00351	CbGpPWpGaD
Triazolam—GABRG3—Transmembrane transport of small molecules—PLN—dilated cardiomyopathy	0.000677	0.00351	CbGpPWpGaD
Triazolam—GABRB1—Transmembrane transport of small molecules—SLC22A5—dilated cardiomyopathy	0.000666	0.00346	CbGpPWpGaD
Triazolam—GABRB1—Transmembrane transport of small molecules—PLN—dilated cardiomyopathy	0.000666	0.00346	CbGpPWpGaD
Triazolam—GABRA6—Transmembrane transport of small molecules—RYR2—dilated cardiomyopathy	0.000648	0.00336	CbGpPWpGaD
Triazolam—CYP2C8—Arachidonic acid metabolism—GPX1—dilated cardiomyopathy	0.000643	0.00333	CbGpPWpGaD
Triazolam—TSPO—myocardium—dilated cardiomyopathy	0.000642	0.0587	CbGeAlD
Triazolam—GABRA4—Transmembrane transport of small molecules—RYR2—dilated cardiomyopathy	0.00064	0.00332	CbGpPWpGaD
Triazolam—GABRA4—heart—dilated cardiomyopathy	0.000633	0.0579	CbGeAlD
Triazolam—GABRA6—Transmembrane transport of small molecules—SLC22A5—dilated cardiomyopathy	0.000631	0.00327	CbGpPWpGaD
Triazolam—GABRA6—Transmembrane transport of small molecules—PLN—dilated cardiomyopathy	0.000631	0.00327	CbGpPWpGaD
Triazolam—GABRG3—Transmembrane transport of small molecules—ABCC9—dilated cardiomyopathy	0.000629	0.00326	CbGpPWpGaD
Triazolam—GABRA4—Transmembrane transport of small molecules—PLN—dilated cardiomyopathy	0.000623	0.00323	CbGpPWpGaD
Triazolam—GABRA4—Transmembrane transport of small molecules—SLC22A5—dilated cardiomyopathy	0.000623	0.00323	CbGpPWpGaD
Triazolam—GABRB1—Transmembrane transport of small molecules—ABCC9—dilated cardiomyopathy	0.00062	0.00321	CbGpPWpGaD
Triazolam—GABRA6—Transmembrane transport of small molecules—ABCC9—dilated cardiomyopathy	0.000586	0.00304	CbGpPWpGaD
Triazolam—GABRB2—Transmembrane transport of small molecules—RYR2—dilated cardiomyopathy	0.000585	0.00304	CbGpPWpGaD
Triazolam—GABRA4—Transmembrane transport of small molecules—ABCC9—dilated cardiomyopathy	0.000579	0.003	CbGpPWpGaD
Triazolam—GABRB2—Transmembrane transport of small molecules—SLC22A5—dilated cardiomyopathy	0.000569	0.00295	CbGpPWpGaD
Triazolam—GABRB2—Transmembrane transport of small molecules—PLN—dilated cardiomyopathy	0.000569	0.00295	CbGpPWpGaD
Triazolam—GABRA5—Transmembrane transport of small molecules—RYR2—dilated cardiomyopathy	0.000569	0.00295	CbGpPWpGaD
Triazolam—GABRB3—BDNF signaling pathway—RPS6KB1—dilated cardiomyopathy	0.000567	0.00294	CbGpPWpGaD
Triazolam—GABRR1—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—RAF1—dilated cardiomyopathy	0.000564	0.00292	CbGpPWpGaD
Triazolam—GABRA3—Transmembrane transport of small molecules—RYR2—dilated cardiomyopathy	0.000558	0.0029	CbGpPWpGaD
Triazolam—GABRA5—Transmembrane transport of small molecules—SLC22A5—dilated cardiomyopathy	0.000553	0.00287	CbGpPWpGaD
Triazolam—GABRA5—Transmembrane transport of small molecules—PLN—dilated cardiomyopathy	0.000553	0.00287	CbGpPWpGaD
Triazolam—GABRA2—Transmembrane transport of small molecules—RYR2—dilated cardiomyopathy	0.000549	0.00285	CbGpPWpGaD
Triazolam—GABRB3—Transmembrane transport of small molecules—RYR2—dilated cardiomyopathy	0.000545	0.00283	CbGpPWpGaD
Triazolam—GABRA3—Transmembrane transport of small molecules—SLC22A5—dilated cardiomyopathy	0.000543	0.00282	CbGpPWpGaD
Triazolam—GABRA3—Transmembrane transport of small molecules—PLN—dilated cardiomyopathy	0.000543	0.00282	CbGpPWpGaD
Triazolam—GABRA1—SIDS Susceptibility Pathways—GJA1—dilated cardiomyopathy	0.000541	0.00281	CbGpPWpGaD
Triazolam—GABRR2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—RAF1—dilated cardiomyopathy	0.000538	0.00279	CbGpPWpGaD
Triazolam—GABRQ—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—RAF1—dilated cardiomyopathy	0.000538	0.00279	CbGpPWpGaD
Triazolam—GABRG2—Transmembrane transport of small molecules—RYR2—dilated cardiomyopathy	0.000535	0.00278	CbGpPWpGaD
Triazolam—GABRA2—Transmembrane transport of small molecules—SLC22A5—dilated cardiomyopathy	0.000534	0.00277	CbGpPWpGaD
Triazolam—GABRA2—Transmembrane transport of small molecules—PLN—dilated cardiomyopathy	0.000534	0.00277	CbGpPWpGaD
Triazolam—GABRB3—Transmembrane transport of small molecules—PLN—dilated cardiomyopathy	0.00053	0.00275	CbGpPWpGaD
Triazolam—GABRB3—Transmembrane transport of small molecules—SLC22A5—dilated cardiomyopathy	0.00053	0.00275	CbGpPWpGaD
Triazolam—GABRB2—Transmembrane transport of small molecules—ABCC9—dilated cardiomyopathy	0.000529	0.00275	CbGpPWpGaD
Triazolam—CYP2C9—Arachidonic acid metabolism—GPX1—dilated cardiomyopathy	0.000523	0.00271	CbGpPWpGaD
Triazolam—GABRG2—Transmembrane transport of small molecules—PLN—dilated cardiomyopathy	0.000521	0.0027	CbGpPWpGaD
Triazolam—GABRG2—Transmembrane transport of small molecules—SLC22A5—dilated cardiomyopathy	0.000521	0.0027	CbGpPWpGaD
Triazolam—GABRA5—Transmembrane transport of small molecules—ABCC9—dilated cardiomyopathy	0.000514	0.00267	CbGpPWpGaD
Triazolam—GABRB3—BDNF signaling pathway—RAC1—dilated cardiomyopathy	0.000512	0.00266	CbGpPWpGaD
Triazolam—GABRA3—Transmembrane transport of small molecules—ABCC9—dilated cardiomyopathy	0.000505	0.00262	CbGpPWpGaD
Triazolam—GABRR1—Ion channel transport—RAF1—dilated cardiomyopathy	0.000502	0.0026	CbGpPWpGaD
Triazolam—GABRA2—Transmembrane transport of small molecules—ABCC9—dilated cardiomyopathy	0.000496	0.00257	CbGpPWpGaD
Triazolam—GABRB3—Transmembrane transport of small molecules—ABCC9—dilated cardiomyopathy	0.000493	0.00256	CbGpPWpGaD
Triazolam—GABRG2—Transmembrane transport of small molecules—ABCC9—dilated cardiomyopathy	0.000484	0.00251	CbGpPWpGaD
Triazolam—GABRE—heart—dilated cardiomyopathy	0.00048	0.0439	CbGeAlD
Triazolam—GABRR2—Ion channel transport—RAF1—dilated cardiomyopathy	0.000479	0.00248	CbGpPWpGaD
Triazolam—GABRQ—Ion channel transport—RAF1—dilated cardiomyopathy	0.000479	0.00248	CbGpPWpGaD
Triazolam—GABRA1—SIDS Susceptibility Pathways—IL10—dilated cardiomyopathy	0.000469	0.00243	CbGpPWpGaD
Triazolam—GABRA1—Transmembrane transport of small molecules—RYR2—dilated cardiomyopathy	0.000468	0.00243	CbGpPWpGaD
Triazolam—GABRA1—Transmembrane transport of small molecules—SLC22A5—dilated cardiomyopathy	0.000455	0.00236	CbGpPWpGaD
Triazolam—GABRA1—Transmembrane transport of small molecules—PLN—dilated cardiomyopathy	0.000455	0.00236	CbGpPWpGaD
Triazolam—TSPO—heart—dilated cardiomyopathy	0.000448	0.0409	CbGeAlD
Triazolam—GABRG3—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—RAF1—dilated cardiomyopathy	0.000443	0.0023	CbGpPWpGaD
Triazolam—GABRB1—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—RAF1—dilated cardiomyopathy	0.000436	0.00226	CbGpPWpGaD
Triazolam—GABRR1—Transmission across Chemical Synapses—RAF1—dilated cardiomyopathy	0.000424	0.0022	CbGpPWpGaD
Triazolam—GABRA1—Transmembrane transport of small molecules—ABCC9—dilated cardiomyopathy	0.000423	0.00219	CbGpPWpGaD
Triazolam—GABRA6—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—RAF1—dilated cardiomyopathy	0.000413	0.00214	CbGpPWpGaD
Triazolam—GABRE—cardiac atrium—dilated cardiomyopathy	0.00041	0.0375	CbGeAlD
Triazolam—GABRA4—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—RAF1—dilated cardiomyopathy	0.000408	0.00211	CbGpPWpGaD
Triazolam—GABRB3—heart—dilated cardiomyopathy	0.000407	0.0372	CbGeAlD
Triazolam—GABRR2—Transmission across Chemical Synapses—RAF1—dilated cardiomyopathy	0.000404	0.0021	CbGpPWpGaD
Triazolam—GABRQ—Transmission across Chemical Synapses—RAF1—dilated cardiomyopathy	0.000404	0.0021	CbGpPWpGaD
Triazolam—CYP2C8—Metabolism of lipids and lipoproteins—ANKRD1—dilated cardiomyopathy	0.000398	0.00206	CbGpPWpGaD
Triazolam—GABRG3—Ion channel transport—RAF1—dilated cardiomyopathy	0.000394	0.00204	CbGpPWpGaD
Triazolam—GABRB1—Ion channel transport—RAF1—dilated cardiomyopathy	0.000388	0.00201	CbGpPWpGaD
Triazolam—TSPO—cardiac atrium—dilated cardiomyopathy	0.000383	0.035	CbGeAlD
Triazolam—CYP2C8—Metabolism of lipids and lipoproteins—TAZ—dilated cardiomyopathy	0.000374	0.00194	CbGpPWpGaD
Triazolam—GABRB2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—RAF1—dilated cardiomyopathy	0.000373	0.00193	CbGpPWpGaD
Triazolam—GABRA6—Ion channel transport—RAF1—dilated cardiomyopathy	0.000367	0.00191	CbGpPWpGaD
Triazolam—GABRA4—Ion channel transport—RAF1—dilated cardiomyopathy	0.000363	0.00188	CbGpPWpGaD
Triazolam—GABRA5—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—RAF1—dilated cardiomyopathy	0.000362	0.00188	CbGpPWpGaD
Triazolam—GABRA3—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—RAF1—dilated cardiomyopathy	0.000356	0.00184	CbGpPWpGaD
Triazolam—GABRA2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—RAF1—dilated cardiomyopathy	0.00035	0.00181	CbGpPWpGaD
Triazolam—GABRB3—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—RAF1—dilated cardiomyopathy	0.000347	0.0018	CbGpPWpGaD
Triazolam—GABRG2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—RAF1—dilated cardiomyopathy	0.000341	0.00177	CbGpPWpGaD
Triazolam—GABRB3—BDNF signaling pathway—RAF1—dilated cardiomyopathy	0.00034	0.00176	CbGpPWpGaD
Triazolam—GABRG3—Transmission across Chemical Synapses—RAF1—dilated cardiomyopathy	0.000333	0.00173	CbGpPWpGaD
Triazolam—GABRB2—Ion channel transport—RAF1—dilated cardiomyopathy	0.000332	0.00172	CbGpPWpGaD
Triazolam—GABRB1—Transmission across Chemical Synapses—RAF1—dilated cardiomyopathy	0.000328	0.0017	CbGpPWpGaD
Triazolam—GABRR1—Neuronal System—RAF1—dilated cardiomyopathy	0.000325	0.00168	CbGpPWpGaD
Triazolam—CYP2C9—Metabolism of lipids and lipoproteins—ANKRD1—dilated cardiomyopathy	0.000324	0.00168	CbGpPWpGaD
Triazolam—GABRA5—Ion channel transport—RAF1—dilated cardiomyopathy	0.000322	0.00167	CbGpPWpGaD
Triazolam—GABRA3—Ion channel transport—RAF1—dilated cardiomyopathy	0.000317	0.00164	CbGpPWpGaD
Triazolam—GABRA2—Ion channel transport—RAF1—dilated cardiomyopathy	0.000311	0.00161	CbGpPWpGaD
Triazolam—GABRA6—Transmission across Chemical Synapses—RAF1—dilated cardiomyopathy	0.00031	0.00161	CbGpPWpGaD
Triazolam—GABRQ—Neuronal System—RAF1—dilated cardiomyopathy	0.00031	0.00161	CbGpPWpGaD
Triazolam—GABRR2—Neuronal System—RAF1—dilated cardiomyopathy	0.00031	0.00161	CbGpPWpGaD
Triazolam—GABRB3—Ion channel transport—RAF1—dilated cardiomyopathy	0.000309	0.0016	CbGpPWpGaD
Triazolam—GABRA4—Transmission across Chemical Synapses—RAF1—dilated cardiomyopathy	0.000307	0.00159	CbGpPWpGaD
Triazolam—CYP2C9—Metabolism of lipids and lipoproteins—TAZ—dilated cardiomyopathy	0.000304	0.00158	CbGpPWpGaD
Triazolam—GABRG2—Ion channel transport—RAF1—dilated cardiomyopathy	0.000303	0.00157	CbGpPWpGaD
Triazolam—GABRA1—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—RAF1—dilated cardiomyopathy	0.000298	0.00155	CbGpPWpGaD
Triazolam—CYP3A7—Metabolism—ANKRD1—dilated cardiomyopathy	0.000283	0.00147	CbGpPWpGaD
Triazolam—GABRB2—Transmission across Chemical Synapses—RAF1—dilated cardiomyopathy	0.00028	0.00145	CbGpPWpGaD
Triazolam—CYP2C9—heart—dilated cardiomyopathy	0.000273	0.025	CbGeAlD
Triazolam—GABRA5—Transmission across Chemical Synapses—RAF1—dilated cardiomyopathy	0.000272	0.00141	CbGpPWpGaD
Triazolam—GABRA3—Transmission across Chemical Synapses—RAF1—dilated cardiomyopathy	0.000267	0.00139	CbGpPWpGaD
Triazolam—CYP3A7—Metabolism—TAZ—dilated cardiomyopathy	0.000266	0.00138	CbGpPWpGaD
Triazolam—GABRA1—Ion channel transport—RAF1—dilated cardiomyopathy	0.000265	0.00138	CbGpPWpGaD
Triazolam—GABRA2—Transmission across Chemical Synapses—RAF1—dilated cardiomyopathy	0.000263	0.00136	CbGpPWpGaD
Triazolam—GABRB3—Transmission across Chemical Synapses—RAF1—dilated cardiomyopathy	0.000261	0.00135	CbGpPWpGaD
Triazolam—GABRG2—Transmission across Chemical Synapses—RAF1—dilated cardiomyopathy	0.000256	0.00133	CbGpPWpGaD
Triazolam—GABRG3—Neuronal System—RAF1—dilated cardiomyopathy	0.000255	0.00132	CbGpPWpGaD
Triazolam—GABRB1—Neuronal System—RAF1—dilated cardiomyopathy	0.000251	0.0013	CbGpPWpGaD
Triazolam—CYP3A7—Metabolism—SDHA—dilated cardiomyopathy	0.000241	0.00125	CbGpPWpGaD
Triazolam—GABRA6—Neuronal System—RAF1—dilated cardiomyopathy	0.000238	0.00123	CbGpPWpGaD
Triazolam—GABRA4—Neuronal System—RAF1—dilated cardiomyopathy	0.000235	0.00122	CbGpPWpGaD
Triazolam—GABRA1—Transmission across Chemical Synapses—RAF1—dilated cardiomyopathy	0.000224	0.00116	CbGpPWpGaD
Triazolam—GABRB2—Neuronal System—RAF1—dilated cardiomyopathy	0.000215	0.00111	CbGpPWpGaD
Triazolam—GABRA5—Neuronal System—RAF1—dilated cardiomyopathy	0.000209	0.00108	CbGpPWpGaD
Triazolam—GABRA3—Neuronal System—RAF1—dilated cardiomyopathy	0.000205	0.00106	CbGpPWpGaD
Triazolam—CYP3A5—Metabolism—ANKRD1—dilated cardiomyopathy	0.000204	0.00106	CbGpPWpGaD
Triazolam—GABRA2—Neuronal System—RAF1—dilated cardiomyopathy	0.000201	0.00104	CbGpPWpGaD
Triazolam—GABRB3—Neuronal System—RAF1—dilated cardiomyopathy	0.0002	0.00104	CbGpPWpGaD
Triazolam—GABRG2—Neuronal System—RAF1—dilated cardiomyopathy	0.000196	0.00102	CbGpPWpGaD
Triazolam—CYP3A5—Metabolism—TAZ—dilated cardiomyopathy	0.000192	0.000997	CbGpPWpGaD
Triazolam—GABRA1—SIDS Susceptibility Pathways—TNF—dilated cardiomyopathy	0.000179	0.000926	CbGpPWpGaD
Triazolam—CYP2C8—Metabolism—ANKRD1—dilated cardiomyopathy	0.000177	0.000918	CbGpPWpGaD
Triazolam—GABRR1—Transmembrane transport of small molecules—RAF1—dilated cardiomyopathy	0.000175	0.000906	CbGpPWpGaD
Triazolam—CYP3A5—Metabolism—SDHA—dilated cardiomyopathy	0.000174	0.000902	CbGpPWpGaD
Triazolam—GABRA1—Neuronal System—RAF1—dilated cardiomyopathy	0.000172	0.00089	CbGpPWpGaD
Triazolam—GABRR2—Transmembrane transport of small molecules—RAF1—dilated cardiomyopathy	0.000167	0.000864	CbGpPWpGaD
Triazolam—GABRQ—Transmembrane transport of small molecules—RAF1—dilated cardiomyopathy	0.000167	0.000864	CbGpPWpGaD
Triazolam—CYP2C8—Metabolism—TAZ—dilated cardiomyopathy	0.000167	0.000863	CbGpPWpGaD
Triazolam—CYP2C8—Metabolism—SDHA—dilated cardiomyopathy	0.000151	0.000781	CbGpPWpGaD
Triazolam—CYP2C9—Metabolism—ANKRD1—dilated cardiomyopathy	0.000144	0.000747	CbGpPWpGaD
Triazolam—GABRG3—Transmembrane transport of small molecules—RAF1—dilated cardiomyopathy	0.000137	0.000711	CbGpPWpGaD
Triazolam—CYP2C9—Metabolism—TAZ—dilated cardiomyopathy	0.000136	0.000703	CbGpPWpGaD
Triazolam—GABRB1—Transmembrane transport of small molecules—RAF1—dilated cardiomyopathy	0.000135	0.000701	CbGpPWpGaD
Triazolam—GABRA6—Transmembrane transport of small molecules—RAF1—dilated cardiomyopathy	0.000128	0.000663	CbGpPWpGaD
Triazolam—GABRA4—Transmembrane transport of small molecules—RAF1—dilated cardiomyopathy	0.000126	0.000655	CbGpPWpGaD
Triazolam—CYP2C9—Metabolism—SDHA—dilated cardiomyopathy	0.000123	0.000636	CbGpPWpGaD
Triazolam—GABRB2—Transmembrane transport of small molecules—RAF1—dilated cardiomyopathy	0.000115	0.000599	CbGpPWpGaD
Triazolam—GABRA5—Transmembrane transport of small molecules—RAF1—dilated cardiomyopathy	0.000112	0.000582	CbGpPWpGaD
Triazolam—GABRA3—Transmembrane transport of small molecules—RAF1—dilated cardiomyopathy	0.00011	0.000571	CbGpPWpGaD
Triazolam—GABRA2—Transmembrane transport of small molecules—RAF1—dilated cardiomyopathy	0.000108	0.000561	CbGpPWpGaD
Triazolam—GABRB3—Transmembrane transport of small molecules—RAF1—dilated cardiomyopathy	0.000108	0.000558	CbGpPWpGaD
Triazolam—GABRG2—Transmembrane transport of small molecules—RAF1—dilated cardiomyopathy	0.000106	0.000548	CbGpPWpGaD
Triazolam—CYP3A4—Metabolism—ANKRD1—dilated cardiomyopathy	9.51e-05	0.000493	CbGpPWpGaD
Triazolam—GABRA1—Transmembrane transport of small molecules—RAF1—dilated cardiomyopathy	9.23e-05	0.000479	CbGpPWpGaD
Triazolam—CYP2C8—Metabolism of lipids and lipoproteins—GPX1—dilated cardiomyopathy	9.19e-05	0.000476	CbGpPWpGaD
Triazolam—CYP2C8—Metabolism of lipids and lipoproteins—CD36—dilated cardiomyopathy	8.95e-05	0.000464	CbGpPWpGaD
Triazolam—CYP3A4—Metabolism—TAZ—dilated cardiomyopathy	8.94e-05	0.000463	CbGpPWpGaD
Triazolam—CYP3A4—Metabolism—SDHA—dilated cardiomyopathy	8.08e-05	0.000419	CbGpPWpGaD
Triazolam—CYP2C8—Metabolism of lipids and lipoproteins—AGT—dilated cardiomyopathy	8.05e-05	0.000418	CbGpPWpGaD
Triazolam—CYP2C9—Metabolism of lipids and lipoproteins—GPX1—dilated cardiomyopathy	7.48e-05	0.000388	CbGpPWpGaD
Triazolam—CYP2C9—Metabolism of lipids and lipoproteins—CD36—dilated cardiomyopathy	7.28e-05	0.000378	CbGpPWpGaD
Triazolam—CYP2C9—Metabolism of lipids and lipoproteins—AGT—dilated cardiomyopathy	6.56e-05	0.00034	CbGpPWpGaD
Triazolam—CYP3A7—Metabolism—GPX1—dilated cardiomyopathy	6.53e-05	0.000339	CbGpPWpGaD
Triazolam—CYP3A7—Metabolism—CD36—dilated cardiomyopathy	6.36e-05	0.00033	CbGpPWpGaD
Triazolam—CYP3A7—Metabolism—AGT—dilated cardiomyopathy	5.73e-05	0.000297	CbGpPWpGaD
Triazolam—CYP3A5—Metabolism—GPX1—dilated cardiomyopathy	4.72e-05	0.000245	CbGpPWpGaD
Triazolam—CYP3A5—Metabolism—CD36—dilated cardiomyopathy	4.6e-05	0.000239	CbGpPWpGaD
Triazolam—CYP3A5—Metabolism—AGT—dilated cardiomyopathy	4.14e-05	0.000215	CbGpPWpGaD
Triazolam—CYP2C8—Metabolism—GPX1—dilated cardiomyopathy	4.09e-05	0.000212	CbGpPWpGaD
Triazolam—CYP2C8—Metabolism—CD36—dilated cardiomyopathy	3.98e-05	0.000207	CbGpPWpGaD
Triazolam—CYP2C8—Metabolism—AGT—dilated cardiomyopathy	3.59e-05	0.000186	CbGpPWpGaD
Triazolam—CYP2C9—Metabolism—GPX1—dilated cardiomyopathy	3.33e-05	0.000173	CbGpPWpGaD
Triazolam—CYP2C9—Metabolism—CD36—dilated cardiomyopathy	3.24e-05	0.000168	CbGpPWpGaD
Triazolam—CYP2C9—Metabolism—AGT—dilated cardiomyopathy	2.92e-05	0.000151	CbGpPWpGaD
Triazolam—CYP3A4—Metabolism—GPX1—dilated cardiomyopathy	2.2e-05	0.000114	CbGpPWpGaD
Triazolam—CYP3A4—Metabolism—CD36—dilated cardiomyopathy	2.14e-05	0.000111	CbGpPWpGaD
Triazolam—CYP3A4—Metabolism—AGT—dilated cardiomyopathy	1.93e-05	9.98e-05	CbGpPWpGaD
